Ancestors

Toot

Written by Christos Argyropoulos MD PhD on 2025-02-06 at 19:06

Invivyd Announces Positive Phase 1/2 Clinical Data for VYD2311, a Monoclonal Antibody Designed to be a Superior Alternative to COVID-19 Vaccination for the Broad Population | NASDAQ https://www.nasdaq.com/press-release/invivyd-announces-positive-phase-1-2-clinical-data-vyd2311-monoclonal-antibody

😎

=> More informations about this toot | More toots from ChristosArgyrop@mastodon.social

Descendants

Written by Auscandoc on 2025-02-06 at 19:42

@ChristosArgyrop I couldn’t immediately see (in the release) what part of the virus the mab targeted. Does it say?

=> More informations about this toot | More toots from auscandoc@med-mastodon.com